AGENTS AND METHODS FOR INCREASING BRAIN CHAPERONIN LEVELS
申请人:Holtzman, Jordan L.
公开号:EP1289512A2
公开(公告)日:2003-03-12
[EN] AGENTS AND METHODS FOR INCREASING BRAIN CHAPERONIN LEVELS<br/>[FR] AGENTS ET METHODES D'AUGMENTATION DES NIVEAUX DE CHAPERONINES CEREBRALES
申请人:HOLTZMAN JORDAN LOYAL
公开号:WO2001089500A2
公开(公告)日:2001-11-29
The invention includes; a method of modulating a level of chaperone protein, a method of modulating a level of ERP57, a method of alleviating a symptom of a disease associated with decreased levels of chaperone proteins, and a method of alleviating a symptom of Alzheimer's disease. The methods include administering to a patient a substituted biphenylmethane compound. Preferably the compound is an analog to methoxychlor. More preferably the compound is methoxychlor. The invention also includes pharmaceutical compositions. The pharmaceutical compositions include substituted biphenylmethanes and a pharmaceutically acceptable carrier. Preferably the pharmaceutical compositions include methoxychlor analogs and a pharmaceutically acceptable carrier. More preferably the pharmaceutical compositions include methoxychlor and a pharmaceutically acceptable carrier.
Structure Proof of 2,2-Bis-(4-fluorophenyl)-1,1-dichloroethane<sup>1</sup>